Import assembly/testing to meet 33% value-addition under EXIM licence for duty exemption rejected after only 5.18% increase

The dominant issue was whether the importer satisfied the EXIM Policy and licence condition of minimum 33% value addition (and corresponding "manufacture") to claim customs duty exemption on imports. Relying on DGFT Policy Circular clarifying that value addition must reflect a tangible increase in intrinsic value and not a paper increase in FOB value, the HC held that assembly/testing yielding only 5.18% value addition did not meet para 11.7 requirements; applying SC precedents on strict construction of exemption conditions, it denied the exemption. Consequentially, non-compliance with licence/notification conditions attracted liability to confiscation under ss. 111(m) and 111(o) of the Customs Act for misdeclaration/non-observance, and the CEGAT view was set aside; the petition was allowed.

---

---

1. ISSUES PRESENTED AND CONSIDERED

1.1 Whether the imports effected under DGFT advance licences and the corresponding exports were in violation of licence conditions and EXIM Policy requirements, particularly the mandatory 33% value addition in intrinsic terms under paragraph 11.7 of the EXIM Policy 1997-2002 and Policy Circular No. 50(RE-99)/99-2000.

1.2 Whether the activities of unpacking, assembling, testing, calibration, software replacement and related processes carried out on the imported ventilator systems amounted to "manufacture" within the meaning of paragraph 3.31 of the EXIM Policy 1997-2002 so as to satisfy the conditions of the advance licence and exemption notification.

1.3 Whether the assessee was entitled to the benefit of exemption from customs duty under the relevant exemption notifications (including Notification No. 1/95-CE and Notification No. 51/2000) in light of the actual value addition achieved and the alleged misrepresentation before the DGFT/JDGFT.

1.4 Whether confiscation of the goods and imposition of duty, interest and penalties under Sections 28, 111(m), 111(o), 113(d), 112, 114 and 114A of the Customs Act, 1962 as ordered by the Commissioner were legally sustainable, and whether the Tribunal erred in setting aside the Order-in-Original by relying on the decision in "Titan Medical Systems".

---

2. ISSUE-WISE DETAILED ANALYSIS

Issue 1: Violation of DGFT licence conditions and EXIM Policy requirements on value addition

Legal framework (as discussed)

2.1 Paragraph 11.7 of the EXIM Policy 1997-2002 permits export against payment in Indian Rupees subject to a minimum value addition of 33%.

2.2 Policy Circular No. 50(RE-99)/99-2000 dated 28.01.2000 issued by JDGFT clarifies that:

(a) The 33% value addition norm is linked to the duty exemption scheme in Chapter VII of the EXIM Policy.

(b) Value addition must be achieved by "effecting an increase in intrinsic value of export products" through tangible processing or manufacturing in India.

(c) Mere increase in FOB value on paper, without increase in intrinsic value, is contrary to the policy, particularly in the context of exports against Rupee payment to Russia under the Rupee Debt Payment Scheme.

Interpretation and reasoning

2.3 The Commissioner, on examination of DRI investigation and bank documents, found that:

(a) Imported ventilator systems were exported substantially as such, after limited assembly, testing and calibration, without any real increase in intrinsic value.

(b) The FOB value of exports was artificially enhanced only on account of the Rupee-Rouble arrangement and not due to any actual value addition.

(c) The original export Letter of Credit for INR 62,45,82,465 was established on 09.08.2000, i.e., after the cut-off date fixed by JDGFT in the Policy Circular, thereby indicating that the transaction fell squarely within the clarified regime requiring intrinsic value addition.

2.4 The Tribunal itself recorded that:

(a) The value of one imported ventilator unit was Rs. 12,91,926/-.

(b) The value of locally procured goods and services used in India was Rs. 67,000/-, resulting in actual value addition of only 5.18%.

(c) The higher rupee export price (Rs. 24,49,393/- per unit) was due to the Rupee-Rouble mechanism and not due to intrinsic value addition.

2.5 Based on these admitted figures, the Court held that:

(a) The minimum 33% intrinsic value addition requirement under paragraph 11.7 and Policy Circular No. 50 was not met.

(b) The respondent's claim before JDGFT of 68.71% value addition (FOB exports of Rs. 55 crores against CIF imports of Rs. 32.59 crores) was contrary to the actual position, which showed only 5.18% value addition.

(c) Mere paper enhancement of FOB value under the Rupee-Rouble arrangement does not qualify as "value addition" under the EXIM Policy.

Conclusions

2.6 The Court concluded that the imports and corresponding exports were in violation of the conditions of the DGFT advance licence and the EXIM Policy, particularly paragraph 11.7 and Policy Circular No. 50(RE-99)/99-2000, as the mandatory 33% intrinsic value addition was not achieved.

---

Issue 2: Whether activities undertaken amounted to "manufacture" under paragraph 3.31 of the EXIM Policy

Legal framework (as discussed)

2.7 Paragraph 3.31 of the EXIM Policy 1997-2002 defines "manufacture" as:

"to make, produce, fabricate, assemble, process or bring into existence by hand or by machine, a new product having a distinctive name, character or use and shall include processes, such as refrigeration, repacking, polishing, labeling and segregation ..."

2.8 The Tribunal relied on:

(a) Rules 12 and 13 of the Central Excise Rules, 1944 (pre-01.07.2001), which, for export purposes, treated processes such as blending, alterations or other operations as "manufacture".

(b) CBEC Circular No. 314/30/97-CE dated 06.05.1997, indicating a liberal approach to "manufacture" for export-oriented units under Notification No. 1/95-CE.

Interpretation and reasoning

2.9 The Tribunal catalogued the processes (B1-B10) undertaken in India, including:

(a) Receipt and inspection of imported and indigenous materials.

(b) Assembly of pneumatic and electronic components into a base ventilator unit.

(c) Assembly of parts and accessories (filters, power cords, humidifier systems, etc.).

(d) Replacement of EPROMs with English software, testing of electrical and pneumatic parameters, system testing.

(e) Fabrication and connection of a communication panel, cabling to display monitor, integration with trolley, and further tests.

(f) Calibration of timing and signal parameters, reintroduction of Russian software, dismantling and repacking for export.

2.10 The Tribunal reasoned that, given the wide export-oriented definition of "manufacture" and the liberal approach adopted in allied excise/export provisions, such processes amounted to "manufacture" and justified the conclusion that manufacturing had taken place in India.

2.11 The Court, however, focused not on the semantic breadth of "manufacture" per se but on whether, even assuming these activities to be "manufacture" in an export context, they resulted in the requisite intrinsic value addition under the EXIM Policy and licence conditions.

2.12 The Court held that, in light of the Tribunal's own finding that actual value addition was only 5.18%, these operations did not bring about the minimum 33% intrinsic value addition mandated by paragraph 11.7 and the Policy Circular. The mere characterization of processes as "manufacture" could not override the explicit quantitative value-add condition.

Conclusions

2.13 The Court held that, irrespective of how "manufacture" under paragraph 3.31 might be liberally construed for exports, the factual value addition (5.18%) fell far short of the mandated 33% intrinsic value addition. Consequently, the activities could not be treated as sufficient "manufacture" for purposes of satisfying the advance licence and exemption conditions.

---

Issue 3: Entitlement to exemption under the notifications and strict construction of exemption conditions

Legal framework (as discussed)

2.14 The exemption from customs duty on imported goods was claimed under exemption notifications including Notification No. 1/95-CE dated 04.01.1995 and Notification No. 51/2000 dated 27.04.2000, which were operative in conjunction with the DGFT advance licence scheme and EXIM Policy requirements on value addition.

2.15 The Court relied on the following Supreme Court decisions:

(a) Eagle Flask Industries Ltd. v. CCE, Pune.

(b) State of Jharkhand v. Ambay Cements.

(c) State of Jharkhand v. La Opala R.G. Ltd.

(d) Novopan India Ltd., as explained in subsequent cases.

(e) CCE v. Mahaan Dairies.

(f) Sanghvi Reconditioners Pvt. Ltd. v. Union of India.

2.16 These authorities, as summarised and quoted by the Court, establish that:

(a) Exemption / exception provisions in taxing statutes are to be strictly construed at the threshold stage of determining eligibility.

(b) The assessee bears the burden of clearly establishing that it falls within the terms of the exemption; any doubt or ambiguity operates in favour of the Revenue.

(c) Conditions attached to an exemption notification or policy must be strictly complied with; courts cannot stretch or add words to confer benefits when the conditions are not met.

(d) Only after the assessee demonstrably satisfies the eligibility clause can the exemption clause itself be construed liberally in its application.

Interpretation and reasoning

2.17 Applying these principles, the Court held:

(a) The foundational condition for exemption here was the achievement of a minimum 33% intrinsic value addition on exports against Rupee payment, as per EXIM Policy paragraph 11.7 and Policy Circular No. 50, read with the licence and notifications.

(b) The Tribunal itself found actual value addition to be 5.18%, and further found that the apparent increase in export price was due to the Rupee-Rouble mechanism and not due to intrinsic value enhancement.

(c) The respondent's declaration to JDGFT of 68.71% value addition (by comparing FOB exports and CIF imports) was inconsistent with the true position of only 5.18% value addition and thus amounted to misrepresentation.

(d) In these circumstances, the assessee had not satisfied the eligibility condition for exemption and could not claim any benefit on the strength of liberal interpretation, certification by other authorities or reliance on case law.

2.18 The Court emphasised that an exemption cannot be granted merely because the licensing authorities did not object or because other authorities supposedly certified "manufacture"; the statutory and policy conditions must be objectively satisfied on facts.

Conclusions

2.19 The Court concluded that the assessee was not entitled to the benefit of the exemption notifications, including Notification No. 1/95-CE and Notification No. 51/2000, because the mandatory condition of 33% intrinsic value addition was not fulfilled and there was misrepresentation in obtaining and operating the advance licence.

---

Issue 4: Validity of confiscation, duty demands, penalties and the Tribunal's reliance on "Titan Medical Systems"

Legal framework (as discussed)

2.20 Sections 111(m) and 111(o) of the Customs Act, 1962 provide for confiscation where:

(a) Goods do not correspond in respect of value or other particulars with the entry made under the Act or declaration (Section 111(m)); and

(b) Goods are exempted from duty subject to conditions, and such conditions are not observed, unless the non-observance is sanctioned by the proper officer (Section 111(o)).

2.21 Section 113(d) provides for confiscation of export goods in certain cases of contravention; Sections 112, 114 and 114A provide for imposition of penalties and penalty equal to duty in specified circumstances. Section 28 governs demand of duty not levied, short-levied or erroneously refunded.

Interpretation and reasoning

2.22 The Commissioner found that:

(a) The respondent had misrepresented to JDGFT at the time of seeking the advance licence by naming a supporting manufacturer who lacked manufacturing capability and by projecting inflated value addition figures.

(b) Goods imported duty-free on conditions of value addition and manufacture were exported substantially as imported, without achieving the required intrinsic value addition, thereby breaching licence and notification conditions.

(c) Consequently, the goods were liable to confiscation under Sections 111(m), 111(o) and 113(d), and the partners and connected persons were liable for penalties under Sections 112, 114 and 114A, along with duty demands under Section 28.

2.23 The Tribunal, however, set aside the Order-in-Original on two principal grounds:

(a) It held that the facts of the case were indistinguishable from "Titan Medical Systems" and, following that precedent, quashed the show-cause notice and order.

(b) It noted that Central Excise Officers had certified manufacture and that DRI officers had permitted exports, relying on this (and BPL case) to infer that manufacture had indeed taken place and that there was no cause to issue a show-cause notice.

2.24 The Court held that the Tribunal's approach was unsustainable because:

(a) The core issue here was objective non-fulfilment of a quantified value-add condition (33% intrinsic value addition), which the Tribunal itself found to be only 5.18%.

(b) In such a scenario, reliance on "Titan Medical Systems" without addressing this critical factual and legal distinction was erroneous. The High Court noted that the case before it concerned breach of conditions in an exemption/advance licence regime, not classification or coverage under an exemption notification.

(c) The mere fact that certain officers had "permitted exports" or certified manufacture could not cure statutory and policy violations or override the strict construction required for exemption conditions.

(d) Given the misrepresentation before JDGFT and the shortfall in value addition, the imported goods, cleared duty-free under conditions subsequently breached, squarely attracted Sections 111(m) and 111(o), and the corresponding demands and penalties under Sections 28, 112, 114 and 114A were justified.

Conclusions

2.25 The Court held that:

(a) The Commissioner's Order-in-Original, ordering confiscation of the goods, demanding duties and imposing penalties under the Customs Act, 1962, was legally sustainable.

(b) The Tribunal erred in law in setting aside the Order-in-Original by mechanically following "Titan Medical Systems" and by not giving effect to the clear finding of only 5.18% value addition and the mandatory 33% intrinsic value-add requirement.

(c) The impugned order of the Tribunal was consequently set aside, and the civil petition was allowed, thereby restoring the Commissioner's order.

---